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Renal proximal tubular epithelium from patients with nephropathic
cystinosis: Immortalized cell lines as in vitro model systems. The renal
proximal tubule is a major site of injury in a variety of congenital!
metabolic diseases including nephropathic cystinosis, the most commonly
known cause of renal Fanconi's syndrome. In this lysosomal storage
disease there are defects in proximal tubule function within the first few
months of life. While culture of renal tubular cells from the urine of these
patients is possible, development of immortalized cell lines would insure
large numbers of homogeneous cells for studies of renal epithelial cell
morphology and pathophysiology in this disease. To develop immortalized
cells, cystinotic and normal proximal tubular cells in culture were exposed
to an immortalizing vector, containing pZiptsUl9 with the temperature
sensitive SV4O T-antigen allele tsA58Ul9 and a neomycin resistance gene,
and neomycin-resistant tubular cells were selected for propagation. Ten
clones from cystinotic patients have been developed and characterized. All
clones express T-antigen at permissive temperature (33°C). Immortalized
cells have an epithelial morphology and grow to form confluent monolay-
ers; doubling times vary from 31 to 86 hours. Cystinotic clones are keratin,
MDR P-glycoprotein, and alpha-95 kD brush-border associated protein
positive but Tamm-Horsfall protein negative by immunocytochemistry, as
are normal proximal tubule cells immortalized with this vector. This is
consistent with a proximal tubule origin of the cystinotic clones. The
cystine content of the cystinotic cells is 70 to 160 times that of normal renal
proximal tubular cells in culture, with most of the cystine sequestered in
cell lysosomes, confirming that these cell lines express the storage defect.
Lysosomes from representative cell lines give a dense lysosome fraction
upon Percoll gradient centrifugation, making it possible to purify lyso-
somes from these cells with no significant contamination by other or-
ganelles. These immortalized cystinotic human renal tubular epithelial cell
lines should seive as a useful in vitro model for the study of tubular
epithelial cell and lysosomal abnormalities in cystinosis, enabling defini-
tion of pathogenesis of tubular cell dysfunction in this prototypic disease.
Many disease processes affect the tubular epithelial cells of the
human kidney. In vitro model systems are available for the study
of extrinsic injury to these epithelia [1—3], and recent progress has
been made in developing human renal immortalized tubular cell
lines from kidneys of normal individuals [4—6]. However, few
model systems exist for the many relatively rare hereditary and
Received for publication January 27, 1995
and in revised form March 20, 1995
Accepted for publication March 20, 1995
© 1995 by the International Society of Nephrology
metabolic disorders that cause early and significant renal tubular
epithelial cell dysfunction and, in many cases, ultimate renal
failure. Few animal models for these rare diseases are presently
available and our knowledge of the cellular and molecular mech-
anisms of these diseases, while substantial, has been derived
primarily from fibroblasts and/or leukocytes from affected indi-
viduals. Renal epithelial cell systems from these individuals would
be very useful in defining cell pathology and pathophysiogical
mechanisms involved.
We have a particular interest in defining renal tubular cell
pathology in nephropathic cystinosis. This disease is an autosomal
recessive disorder in which cystine accumulates in lysosomes due
to a defect in a lysosomal membrane cystine transporter [7]. The
earliest manifestation of this disease is renal tubular Fanconi's
syndrome, beginning within the first six months of life and leading
to major nutritional deficits, with ultimate progression to renal
failure by the second to third decade [8]. Early treatment with
cysteamine, a thiol compound which depletes lysosomes of stored
cystine [9], markedly extends renal survival [10]. Very early
treatment of these patients with cysteamine may also prevent
Fanconi's syndrome, but intervention must begin very early in life
and is not always successful [10]. Moreover, many patients are
only diagnosed after defects in renal tubular absorption have
already developed.
Attempts have been made to develop model systems for
nephropathic cystinosis, but most of these have relied upon acute
cell loading with cystine via administration of cystine-dimethyl
ester in vitro, an experimental setting which is not completely
analogous to the cell injury seen in this storage disorder. Since we
have had success in culturing human renal epithelial cells from the
urine of subjects with normal kidneys [11], we attempted to
culture renal tubular cells from the urine of young patients with
cystinosis who had not yet suffered renal failure, as a benign and
non-invasive way of obtaining these mutant epithelial cells for
study. We have had substantial success with this approach, having
retrieved and cultured epithelial cells from the urine of a signifi-
cant number of these patients. Upon characterization of these
cells, many were shown to have the morphology and histochemical
properties of cells of renal proximal tubular origin [12].
However, since primary culture systems have a limited life span
in vitro and can undergo only a limited number of passages, there
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are difficulties in utilizing such cultures on an ongoing basis for
controlled studies. Moreover, repeated harvesting is tedious and
time consuming. Despite strategies including a mild salicylate
challenge, cell numbers obtained from each isolate are relatively
small, and the cell population obtained in this way is potentially
heterogeneous. Therefore, we decided to develop immortalized
clonal cell lines from stores of cryopreserved renal cells from
patients with cystinosis. We now describe the development and
characterization of a number of clones of immortalized renal
tubular cells from two of these patients. These cell lines express
differentiation markers consistent with proximal tubular origin,
and express the lysosomal cystine accumulation which is charac-
teristic of the cystinsosis phenotype. Analysis of cell organelles
from a number of these clones on Percoll gradient centrifugation
reveals a large dense lysosome fraction apparently free of signif-
icant contamination from other organelles. These cell lines rep-
resent the first available in vitro system for study of epithelial cells
in this disorder.
Methods
As described in our previous report [12], clean catch 24-hour
urine specimens were obtained from two patients with nephro-
pathic cystinosis being evaluated at the NIH Clinical Research
Center per a protocol approved by institutional review boards at
the Johns Hopkins University School of Medicine and at the NIH.
Specimens were refrigerated until processed. Urine aliquots were
centrifuged at 72 X g for five minutes, and the pellets resuspended
in culture medium and seeded into culture vessels. Cells were
grown in basal medium, a 1:1 ratio of Hams F12:DMEM (Dul-
becco's Modified Essential Medium) with 25 mrvi Hepes, 10%
FBS, 50 /ml penicillin, 50 sg/ml streptomycin, and 2.5 g/ml
Amphotericin. Cells were propagated, passaged, and then frozen
at —80°C in basal medium + 10% DMSO until retrieval for
immortalization.
For development of the immortalizing recombinant retrovirus,
the plasmid pZipneoTA58Ul9 was used; this plasmid has been
used previously to immortalize human CNS precursor cells [13].
The T-antigen segment is the BglI (5234) to HpaI (2666) fragment
of SV4O containing both the ts A58 (conferring temperature
sensitivity [14]), and U19 (enhancing transfection efficiency [15])
mutations. The construct also contains a neomycin resistance gene
and a modified Moloney Murine Leukemia Virus long terminal
repeat (Fig. 1). The construct was confirmed by restriction
mapping, and the plasmid was then transfected into the psi-CRIP
amphotropic packaging cell line [16].
PZipneoTAS8Ul9 was introduced into psi-CRIP cells using
calcium phosphate coprecipitation. After overnight transfection,
cells were placed in fresh basal medium for 48 hours, and clones
were then selected in the presence of 1 mg/ml geneticin (G418).
Resistant colonies were harvested and propagated, and superna-
tants from them titered in cultures of 3T3 cells [16]. Briefly,
supernatants were serially diluted in basal medium and intro-
duced into culture vessels in the presence of polybrene (6 tg/ml).
After overnight incubation, the supernatants were removed and
replaced by basal medium containing G418. After 8 to 10 days,
resistant colonies were counted and colony-forming units calcu-
lated. Two clones, PZA 11 and PZA 13, produced supernatants
containing 4 X 10" and 3.6 X io colony forming U/ml, respec-
tively, which were then used to immortalize cultured cystinotic
Fig. 1. Schematic of the recombinant retrovirusplasmidpZlPneoTA58Ul9
used to construct the immortalizing vector. The construct contains an SV4O
large T antigen segment containing tsA58 and U19 mutations, conferring
temperature sensitivity and enhanced transfection efficiency. It also con-
tains a neomycin resistance gene (neo) and a Modified Moloney Murine
Leukemia Virus long terminal repeat (MMLV-LTR). The construct was a
gift of Dr. R. McKay.
and normal renal tubular cells. Supernatants were flash frozen in
liquid nitrogen and stored at —80°C until use.
Cryopreserved cystinotic cells cultured from isolates from two
unrelated patients (CYS 60 and CYS 92) were retrieved from
cyropreservation and seeded in basal culture medium into 35 mm
culture plates (Falcon; 1 x io cells/plate). Supernatants from
PZA 11 and PZA 13 were introduced with polybrene for a 24 hour
incubation. The supernatant was then removed and neomycin
selection was begun with G418 at 1 mg/ml in basal medium. At 8
to 10 days, well-spaced resistant colonies were trypsizined from
the growth surfaces, transferred to individual wells in 24-well
plates, fed and monitored for attachment and growth. A number
of clones were developed from each isolate and propagated at
33°C (permissive temperature).
Normal human proximal tubule epithelia were obtained by
explant culture of kidney cortex from normal human nephrectomy
specimens plated in serum-free medium supplemented with spe-
cific growth factors previously shown to be selective from growth
and differentiation of proximal straight tubule cells [1, 17].
Rapidly proliferating epithelia were treated with pZA superna-
tants as described above and G418 resistant cells were cloned by
limiting dilution. Origin from proximal straight tubule of the
clones of immortalized cells used for these studies was confirmed
by marker analysis, for alkaline phosphatase, aminopeptidase N,
CHIP-28, and MDR (P. Wilson, data not shown).
Clones of immortalized cystinotic cells were subsequently char-
acterized. Cell morphology in culture and growth kinetics, mea-
sured as doubling times calculated during exponential growth
phase, were monitored. Clones were also assessed for expression
of T-antigen using a murine monoclonal antibody to large T-
antigen and an indirect immunofluorescence technique; slides
were visualized using a Zeiss fluorescence microscope. For assess-
ment of cellular differentiation, cystinotic cells were seeded on
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Matrigel, and grown to confluence at 39°C (non-permissive tem-
perature) for six days in Hams F12:DMEM containing 2.5%
serum with hormonal suppimentation (2.5 g/ml insulin, 0.05
gfml hydrocortisone, 5 j.g/ml transferrin; 5 ng/mI sodium selen-
ite and 20 nglml triiodothyronine). They were then stained for
various proximal and distal nephron markers using a streptavidin
biotin immunoperoxidase technique (Vector Laboratories [18])
with primary antibodies against cytokeratin (epithelium), Tamm-
Horsfall protein (distal tubule), and MDR P-glycoprotein and
alpha-95 kD brush border protein (proximal tubule). Positive
controls were frozen sections of human kidney and normal human
kidney cells immortalized with the same recombinant vector
selected with G418 and cloned; negative controls were monolay-
ers stained following omission of the primary antibody or stained
following exposure to non-immune serum.
Cystine levels were measured on whole cell suspensions and on
granular fractions from each cystinotic cell line and from normal
controls within five days of reaching confluence. Whole cell
cystine was also determined in one normal and two cystinotic
clones maintained at confluence for four weeks, to assess influ-
ence of incubation time on cystine accumulation. Isolation of the
granular fraction, enriched in lysosomes, was prepared from
cultures grown to confluence at 37°C in four 100 mm2 Primaria
dishes (Falcon) in the presence of Hams F12:DMEM with 2%
FBS and media supplements (see above). Cultures were placed on
ice, then washed and harvested by scraping into 0.25 M sucrose, 5
mM EDTA, pH 7.0 (sucrose!EDTA) and sedimented briefly at 70
g. For measurements of total cell cystine levels, cell pellets from
two dishes were resuspended in 5 X volume of 10 mM N-
(ethyl)maleimide in 10 m sodium phosphate buffer (NEM/P04).
For isolation of the granular fraction, pelleted cells from the
remaining two dishes were resuspended to 5 X volume in sucrose!
EDTA containing proteinase inhibitors (2 mis phenylmethyl
sulfonyl fluoride, 10 tM pepstatin, 1 g/ml leupeptin and 1 jLg/ml
aprotinin). Cells were disrupted by aspiration through a Pasteur
pipette, and cell rupture monitored by microscopic observation of
nuclear release. Nuclei and cellular debris were sedimented at 200
X g for 10 minutes. The supernatant containing organelles,
plasma membrane vesicles and soluble protein was then centri-
fuged at 20,000 X g for 10 minutes, and the pellet, resuspended in
a minimum volume of NEMIPO4 with proteinase inhibitors (see
above), was taken as the granular fraction enriched in lysosomes.
f3-hexosaminidase was measured fluorometrically by the cleavage
of 4-methylumbeliferyl, 4-acetyl-j3-D-glucosaminide using the
method of Fisher et al [19]. Cystine levels in total cell and granular
fractions were determined using a bioassay method [20], with
results standardized as nmoles 1/2 cystine (cysteine) per mg
protein. Protein was determined using the BCA reagent. (Pierce).
Recovery of /3-hexosamidase and cystine in granular fractions
were calculated as a percent of the total values measured in the
corresponding whole cell suspension.
Lysosomal vesicle isolation
Lysosomes were isolated from 5 X i07 normal human and
cystinotic renal cells essentially as described above in a 0.25 M
sucrose, 5 mM EDTA buffer, pH 7.0 containing proteinase inhib-
itors (2 mri phenyhnethylsulfonyl fluoride, 10 j.tM pepstatin, 1
Lgfml leupeptin, and 1 .tg/ml aprotinin). Lysosomes were further
separated from other cellular organelles in the granular fraction
on a 25% Percoll density gradient (Pharmacia) and 0.5 ml
fractions collected. Aliquots of each step in the purification and
each fraction from the Percoll gradient were assayed for protein
content, for alkaline phosphatase activity to localize plasma
membrane vesicles, for j3-hexosaminidase as a measure of lysoso-
mal integrity, and for j3-glucosidase as a marker for lysosomal
membranes. Alkaline phosphatase was assayed spectrophoto-
metrically by the cleavage of p-nitrophenylphosphate [21] in 50
mM glycine, pH 10.5, containing 0.25 mM MgCl2, 2.5 m zinc
acetate, and 5 mi CaC12. Reactions were stopped with the
addition of 5 N NaOH and p-nitrophenol (PNP) was used as
standard. J3-hexosaminidase activity [19] was used to track purifi-
cation of intact lysosomes as described above. /3-glucosidase was
assayed by the hydrolysis of 4-methylumbelliferyl j3-D-glucoside
[22] in 0.1 M KPO4, pH 5.9, with 0.25% sodium taurocholate and
0.15% Triton X-100; 0.2 M glycine, pH 10, was used to stop the
reactions. The fluorescent product, methylumbelliferone (MeU)
was used to standardize both -hexosaminidase and 13-glucosidase
activity. Protein was estimated with the Bradford reagent (Bio-
Rad) with BSA as standard.
In a refinement of these methods, 1 m CaCl2 was added to
granular fractions prior to Percoll gradient centrifugation in order
to decrease the buoyant density of the mitochondria, which could
contaminate the dense lysosome peak. Assays were performed
for a-mannosidase (Golgi vesicles) and cytochrome C oxidase
(mitochondria) as described by Storrie and Madden [23]. Alpha-
mannosidase activity was measured by the cleavage of 4-methy-
lumbellifeiyl-a-D-mannopyranoside in (Dulbecco's) PBS. Cyto-
chrome C oxidase activity of Percoll fractions was measured
spectrophotometrically as a decrease in absorbance at 550 nm in
the presence of reduced cytochrome C in PBS.
Reagents. Hams F12:DMEM, fetal bovine serum, and antibiot-
ics were from Gibco Laboratories (Grand Island, NY, USA).
Matrigel was purchased from Beckton Dickinson Laboratories
(Bedford, MA, USA). All other chemicals and media supplements
were obtained from Sigma Chemical Company (St. Louis, MO,
USA). The plasmid pZIPNe0TA58U19 was a gift from Dr. R.
McKay, (MIT) and the psi-CRIP cell line was provided by Dr.
R.C. Mulligan (MIT). Murine monoclonal antibody 419 to SV4O
TAg was a gift from Dr. Thomas Kelly (JHMI); antibody to MDR
P-glycoprotein was obtained from Dr. Suresh Ambudkar (JHMI).
Cytokeratin antibody was obtained from Biomedical Technology,
Inc. (Stoughton, MA, USA) and antibody against Tamm Horsfall
protein from The Binding Site (San Diego, CA, USA). Antibody
to alpha-95 brush border associated protein was a gift from Dr. M.
Farquhar (Yale University). Immunocytochemistry was per-
formed using the Vectastain kit and aminoethylcarbazole from
Vector Laboratories, (Burlingame, CA, USA). All reagents for
lysosome isolation and enzyme assays were purchased from Sigma
Chemical Company.
Results
A total of ten clones of cystinotic renal tubular cells were
developed from cystinotic culture isolates CYS 60 and CYS 92
using supernatants from the two psi-CRIP clones (pZA11,
pZA13) which had been transfected with pZipneoTA58Ul9 and
which produced high-titer immortalizing supernatants. All cysti-
notic clones demonstrated a monolayer growth pattern; phase
micrographs of three representative clones are shown in Figure 2.
Doubling times for all ten clones varied between 31 and 86 hours,
at 33°C (permissive temperature; Table 1). Cells from all normal
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Fig. 2. Phase contrast micrographs of three representative clones of cystinotic tubular cells photographed at or near confluence. The cells show a monolayer
growth pattern and have polygonal, epithelial cell morphology. (A. CYS 60.11.7 (x115); B. CYS 60.11.2 (X230); C. CYS 92.13.1 (x115).
Table 1. Properties of cystinotic renal tubular cell clones
Clone Growth
Doubling
time hours T ag
Cystine nmol 1/2
cystine/mg protein
CYS 60.11.1 Monolayer 47 ÷a 574
CYS 60.11.2 Monolayer 48 + 8.18
CYS 60.11.7 Monolayer 86 + 7.55
CYS 92.11.1 Monolayer 38 + 4.50
CYS 92.11.3 Monolayer 31 + 3.25
CYS 92.11.5 Monolayer 38 + 5.70
CYS 92.13.1 Monolayer 50 + 7.31
CYS 92.13.2 Monolayer 44 + 5.01
CYS 92.13.3 Monolayer 41 + 5.79
CYS 92.13.5 Monolayer 46 + 7.99
NHK-PST' Monolayer 48 + 0.06
a Positive stainingb NHK-PST is a non-clonal pool of normal human kidney proximal
tubular cells grown from explant cultures and immortalized using the same
recombinant DNA vector used to develop the CYS clonal cell lines.
and cystinotic clones strongly express large T-antigen at 33°C, with
some heterogeneity in intensity of staining among cells within
each clone. Growth for six days at 39°C reduced but did not
eliminate T-antigen staining.
Cells from the cystinotic clones were assayed for cell cystine and
results compared to cystine levels in control normal human
proximal tubule epithelial cells immortalized with the same
supernatants (Table 1). Cell cystine levels of the immortalized
normal human proximal tubule (NHK-PST) cells averaged 0.06
nmoles 1/2 eystine/mg protein. These values are nearly identical to
those previously determined for normal human renal tubular cells
in primary culture [12]. In contrast, the cystinotic clones have
comparatively high cystine levels, varying from 3.25 to 8.18 nmoles
1/2 cystine/mg protein. Cell fractionation studies (Table 2) dem-
Table 2. Recovery of granular fraction (G.F.) and whole cell lysosomal
/3-hexosaminidase and cystine
Beta-hexosaminidase activity
total nrnol Meu TotaI nmol 1/2 cystine
Whole % Whole %
Culture G.F. cell Recoverf G.F. cell Recovery
CYS 60.11.1 138 158 87 6.706 6.872 98
CYS 60.11.2 64 151 42 4.606 5.071 91
CYS 60.11.7 59 172 34 2.308 3.101 74
CYS 92.11.1 216 605 43 9.195 9.479 97
CYS 92.11.3 170 455 37 4.914 7.029 70
CYS 92.11.5 235 360 65 5.308 7.481 71
CYS 92.13.1 126 251 50 4.437 5.634 77
CYS 92.13.2 66 209 32 1.976 4.695 42
CYS 92.13.3 107 269 40 4.830 5.695 86
NHKPSTb 89 231 35 0.039 0.068 57
NHK-PST 51 118 43 0.052 low —
a (G.F./whole cell) X100
b NHK-PST is a non-clonal pool of normal human kidney proximal
tubular cells grown from explant cultures and immortalized using the same
recombinant DNA vector used to develop the CYS clonal cell lines.
onstrated that the cell cystine is largely sequestered in the
lysosomal fraction; recovery of cystine was proportional to recov-
ery of 13-hexosaminidase (a marker of intact lysosomes) in the
granular fractions from these cells. These results confirm the basic
storage defect in the cystinotic cell lines. Comparison of the clones
assayed immediately after reaching confluence and later after four
weeks at confluence showed no increase in cystine accumulation
with time in culture.
By immunoperoxidase staining, all cells from the immortalized
NHK-PST and cystinotic clones were shown to be cytokeratin
positive, confirming their epithelial origin (Table 3, and Fig. 3).
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Table 3. Expression of differentiation markers by immunocytochemistry
in cystinotic renal tubule cell lines
Clone Keratin
MDR
P-glycoprotein
alpha 95 kd
brush border
protein
Tamm-
Horsfall
protein
CYS 60.11.1 2-3+ 1-2+ 2-3+ 0
CYS6O.11.2 3+ 2+ 1+ 0
CYS 60.11.7 3+ 3+ 1-2+ 0
CYS 92.11.1 2-3+ 1+ 2-3+ 0
CYS 92.11.3 1+ 1-2+ 1-2+ 0-1+
CYS 92.11.5 1+ 1-2+ 1-2+ 0-1+
CYS 92.13.1 3+ 1+ 1-2+ 0
CYS 92.13.2 1-3+ 1+ 2-3+ 0
CYS 92.13.3 1+ 1-2+ 1-2+ 0
CYS 92.13.5 1+ 1+ 1-3+ 0
NHK-PST 3+ 2+ 2+ 0
Semiquantitative grading (scale 0 to 3+) of immunoperoxidase staining
for keratin (epithelium), MDR P-glycoprotein and alpha 95 kd brush
border protein (proximal nephron), and Tamm-Horsfall protein (distal
nephron).
Fig. 3. ABC-immunoperoxidase stain for cytokeratin, an epithelial cell
marker, in a representative cystinotic clone, CYS 92.11.1 (X250). Note the
filamentous intracellular staining.
Results of immunoperoxidase staining for cell expression of a
variety of segment-specific antigens are shown in Table 3. Markers
included the alpha-95 kD brush-border associated protein and
MDR p-glycoprotein, specific for proximal tubule; and Tamm-
Horsfall protein, specific for more distal nephron [24]. Clones
express markers for proximal tubule comparable to the pattern of
staining seen with the normal human proximal tubule cells [1, 24].
However, some heterogeneity in intensity of staining was seen
among the cystinotic clones (Table 3). Photomicrographs of
monolayers stained for proximal tubule markers (MDR-P-glyco-
protein and alpha-95 kD brush border associated protein) in a
representative cystinotic clone, CYS 92.11.5, are shown in Figure
4. This clone showed 1 to 2+ staining for both of these antigens.
The results of Percoll density gradient fractionation of repre-
sentative clones are given in Figure 5. Parts A and B show total
13-hexosaminidase (mol MeU) and total alkaline phosphatase
(nmol PNP) activity for one cystinotic clone and one normal
clone. Alkaline phosphatase activity, a marker for brush border
plasma membrane vesicles, peaked at fractions 2 to 3 from the top
of the gradient and became negligible after fraction 6 (Fig. 5 A,
B). Assay of /3-hexosaminidase activity indicates dense lysosomes
are concentrated below fraction 7 (Fig. 5 A, B, C, D). In panels C
and D of Figure 5, 13-hexosaminidase and f3-glucosidase activities
are shown. These markers show identical distribution along the
Percoll gradient as was expected since both are markers for
lysosomes. The cystinotic clones also show a bimodal distribution
of lysosomal enzyme markers, indicative of the classic light and
dense lysosome populations, present in many normal renal cell
lines including LLC-PK1. The dense lysosomal fraction is free of
markers for the Golgi apparatus and for mitochondria, which
segregate in fractions 2 to 3 (not shown). Each cystinotic and
normal clone displays a reproducible and characteristic pattern of
lysosomal marker activity, indicating variable proportions of light
and dense lysosomal populations.
Discussion
The cellular defects in a variety of metabolic diseases affecting
the renal nephron have not been defined. This is due, in large
part, to lack of model systems in which to study these disorders.
With few exceptions, there are no true animal models for these
diseases. While leukocytes and fibroblasts may be harvested from
affected patients for study, these cells largely lack the specialized
functions of the epithelial cells impacted by the disease.
Attempts have been made to model nephropathic cystinosis by
acute exposure of kidney cells to cystine dimethylester (CDME),
a membrane-permeable form of the amino acid which enables
rapid cell and lysosome loading with cystine. Using this model,
Foreman et al [25] and Salmon and Baum [26] found that CDME
loading inhibited volume absorption, transepithelial potential
difference, glucose transport, and bicarbonate transport in per-
fused rodent proximal convoluted tubules. Coor et al subse-
quently showed that exogenous ATP ameliorated the transport
inhibition in this model [27]. Ben-Nun et al acutely loaded
cultured LLC-PK1 cells, a porcine cell line with characteristics of
proximal tubule, and found decreased Na,K-ATPase activity and
reduction in number and activity of plasma membrane transport-
ers [28]. While these results are intriguing, acute CDME toxicity
may not truly model the cellular abnormalities in the human
storage disease in which cystine accumulates gradually over time.
Also, these systems are obviously not useful for defining the
abnormal gene(s) and gene product(s) underlying this storage
disease.
To develop model renal epithelial cell primary culture systems
which truly express the mutation in nephropathic cystinsosis, we
employed a non-invasive strategy which we and others had
previously utilized to harvest human renal cells [11, 29—32]. In
previous studies [12], we had obtained urine specimens from
patients with nephropathic cystinosis, centrifuged the specimens,
resuspended the sedimented cells, and placed them in culture
vessels. Cell monolayers were obtained from 69% of the speci-
mens which contained renal epithelial cells and which were not
contaminated. Fifty-eight percent of these grew to confluent
monolayers and could be passaged and/or cryopreserved. Mono-
layers had an epithelial appearance by phase and electron micros-
copy and the majority of cells in the monolayers expressed brush
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Fig. 4. ABC-iinrnunoperoxidase stains for alpha 95 kD brush border associated protein (A) (X400) and MDR P-glycoprotein (B) (X250) on a representative
cystinotic clone, 92.11.5. Punctate surface staining is clearly seen.
border enzymes typical of renal proximal tubule. These cells also
had high levels of intracellular cystine, which could be depleted by
exposure to cysteamine.
While many of the epithelial cells cultured from the urine of
cystinotic patients originated from the renal proximal tubule,
other cells were of more distal origin. However, because of the
small numbers of cells it was not possible to purify them and
isolate homogeneous proximal (or distal) tubular cells. Even with
salicylate challenge, a strategy utilized previously to enhance
shedding of renal tubular epithelial [32], cell numbers remained
small. Moreover, since cells from one individual may differ from
those of another, each isolate must serve as it's own control; cell
numbers obtained from each isolate were too small to perform
such controlled studies. Lysosomal isolations that could further
delineate the membrane transport defect were also not possible. It
became necessary to develop immortalized renal epithelial cell
lines from these isolates in order to provide the large numbers of
mutant cells required for definitive in vitro studies.
We had previously developed normal renal epithelial cell lines
using an Adeno-12:SV40 hybrid immortalizing virus containing
the Adeno EIA and SV40 large T antigens. A number of clones
developed with this agent retained characteristics of renal proxi-
mal tubule epithelium [4, 5]. However, the Adeno-12-SV40
recombinant lacks a dominant selectable marker enabling early
selection of transfected cells, and also has high level constitutive
expression of T-antigen. Therefore, for immortalizing cysti-
notic renal tubular cells, we used a retrovirus construct
pZIPneoTA58U19 encoding the mutant SV4O large T-antigen
A58U19, which produces a temperature-sensitive expression of
large T-antigen, and has the Tn5 neomycin resistance gene as a
dominant selectable marker. With the recombinant retrovirus
vector generated using this plasmid and the amphotropic packag-
ing line psi CRIP, we have succeeded in developing clonal lines of
immortalized cystinotic renal epithelial cells.
Clones of renal tubular cells from two cystinotic patients from
different kindreds have been characterized. All clones express
markers of proximal tubular cell differentiation, and all express
the lysosomal cystine storage defect; normal human renal proxi-
mal tubular cell lines immortalized with the same vector have
similar properties but lack the storage defect. The levels of cystine
contained in these cells (3.25 to 8.18 nmol 1/2 cystine/mg protein)
is in the range reported for cystinotic renal tubular cells in primary
culture (4.0 0.3 nm/mg) [12, 33] and for cystinotic fibroblasts
(6.4 to 9.6 nm/mg) [34], as well as for cystinotic fibroblast cell lines
[35]. They are significantly (10- to 40-fold) higher than levels in
transformed cystinotic lymphoblasts [34]. These levels are lower
than those reported for liver (45.8 to 112.5 nm/mg), pancreas (35.8
nm/mg), and native kidney (16.7 to 101.7 nm/mg) in situ [8]; the in
situ organ cystine levels presumably represent long-term accumu-
lation in tissues with low cell turnover. All cystine levels reported
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osaminidase (•; ymol MeU); and (3-glucosidase
(A; junol MeU); recovered in granular fractions
prepared from cystinotic (A, C, D) and normal (B)
proximal tubule cell lines.
here were performed on confluent monolayers. We have also
assessed cystine accumulation over time in stationary monolayer
cultures in order to test the hypothesis that cystine accumulation
increases over time in cells with low mitotic activity; however, no
additional accumulation of cystine was seen. These results are
similar to those reported in a cystinotic fibroblast cell line [33J. In
addition cell cystine levels in our cultures do not appear to
correlate with isolate of origin nor with passage number.
Cystine storage in lysosomes appears to be directly related to
the cellular defects in nephropathic cystinosis, since depletion of
cell cystine with cysteamine significantly delays and/or alleviates
symptoms of the disorder. The cystinotic epithelial cell lines
described herein have discrete lysosomal peaks on gradient
centrifugation of cell lysates, making it possible to isolate dense
lysosomes for studies of physicochemical, structural, and transport
properties. While some studies of discrete lysosomal properties
have been carried out in cystinotic fibroblasts and leukocytes
[36—40], these cells display no known alterations in function in
this storage disease. Cystinotic renal epithelial cell lines enable
study of lysosomal abnormalities in a systematic fashion in mutant
epithelial cells and allow correlation between lysosomal and
cellular abnormalities in the disorder.
In summary, renal tubular cell defects are an early manifesta-
tion and major cause of morbidity in patients with nephropathic
cystinosis. The immortalized renal tubular cell lines we have
developed from cystinotic patients express the lysosomal cystine
transport defect and should be ideal for the study of the cellular
abnormalities underlying this disease. These clones appear to be a
unique model for the study of early lysosome abnormalities in
cystinosis, and should prove to be a useful tool for defining the
molecular pathology in this disorder. Moreover, the general
strategy we have employed of urine cell isolation and immortal-
ization should prove useful for developing renal epithelial cell
lines from other patients with relatively rare genetic disorders
affecting the renal tubule.
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